In observance of Memorial Day, the IMSMP will be closing on 5/26/23 at 1:00PM and will reopen on 5/30/23 at 9:00AM

By choosing Tisch MSRCNY as your charitable recipient on Amazon Smile, Amazon will donate to our laboratory at no additional cost to you.

...

The FDA recently approved ublituximab (Briumvi^TM) for the treatment of relapsing forms of Multiple Sclerosis. Ublituximab is a member of the anti-B cell (anti-CD20 monoclonal antibody) family of drugs, which includes rituximab (Rituxan^TM), ocrelizumab (Ocrevus^TM), and ofatumumab (Kesimpta^TM). The primary difference between these drugs is how they are administered and the length of time required to safely administer the medication. Ublituximab, like...